12.36
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché RDY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$13.24
Aprire:
$12.71
Volume 24 ore:
2.80M
Relative Volume:
1.60
Capitalizzazione di mercato:
$2.12B
Reddito:
$3.47B
Utile/perdita netta:
$668.83M
Rapporto P/E:
3.0802
EPS:
4.0127
Flusso di cassa netto:
$253.46M
1 W Prestazione:
-6.36%
1M Prestazione:
-3.51%
6M Prestazione:
-21.04%
1 anno Prestazione:
-15.20%
Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile
Confronta RDY con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
RDY
Dr Reddys Laboratories Ltd Adr
|
12.36 | 2.12B | 3.47B | 668.83M | 253.46M | 4.0127 |
![]()
ZTS
Zoetis Inc
|
151.73 | 69.57B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.72 | 47.40B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
HLN
Haleon Plc Adr
|
9.89 | 46.06B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.80 | 15.98B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
292.46 | 13.58B | 2.76B | 1.11B | 898.10M | 22.77 |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-19 | Downgrade | Nomura | Buy → Neutral |
2024-01-11 | Downgrade | Jefferies | Buy → Underperform |
2023-08-29 | Downgrade | HSBC Securities | Buy → Hold |
2023-05-18 | Downgrade | Bernstein | Outperform → Mkt Perform |
2023-03-17 | Aggiornamento | BofA Securities | Neutral → Buy |
2023-01-30 | Iniziato | JP Morgan | Underweight |
2022-11-14 | Downgrade | Credit Suisse | Neutral → Underperform |
2022-01-03 | Ripresa | BofA Securities | Neutral |
2021-07-27 | Downgrade | Credit Suisse | Outperform → Neutral |
2021-02-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
2020-09-18 | Aggiornamento | BofA Securities | Neutral → Buy |
2020-09-18 | Aggiornamento | Investec | Sell → Hold |
2020-01-28 | Downgrade | CLSA | Buy → Outperform |
2020-01-27 | Downgrade | CLSA | Buy → Outperform |
2020-01-09 | Aggiornamento | Citigroup | Sell → Buy |
2019-11-04 | Downgrade | BofA/Merrill | Buy → Neutral |
2019-09-04 | Aggiornamento | Credit Suisse | Underperform → Outperform |
2019-07-01 | Aggiornamento | Macquarie | Neutral → Outperform |
2019-06-20 | Iniziato | Deutsche Bank | Hold |
2019-06-11 | Iniziato | Barclays | Equal Weight |
2019-05-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2019-02-19 | Aggiornamento | CLSA | Outperform → Buy |
2019-01-17 | Downgrade | Citigroup | Neutral → Sell |
2017-09-21 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2017-08-31 | Aggiornamento | CLSA | Underperform → Outperform |
2017-07-28 | Downgrade | CLSA | Underperform → Sell |
2016-07-27 | Downgrade | HSBC Securities | Hold → Reduce |
2016-07-27 | Downgrade | Jefferies | Hold → Underperform |
2016-02-10 | Aggiornamento | Credit Agricole | Underperform → Buy |
2015-11-10 | Downgrade | Citigroup | Buy → Neutral |
Mostra tutto
Dr Reddys Laboratories Ltd Adr Borsa (RDY) Ultime notizie
Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday Trading - TradingView
American Healthcare REIT Inc (AHR) Stock: A Year of Decreases and Increases - The InvestChronicle
Asian Equities Traded in the US as ADRs Rise in Tuesday Trading - MSN
Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - TradingView
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Asian Equities Traded in the US as American Depositary Receipts Lower in Friday Trading - TradingView
Infosys, Wipro, TCS, other IT stocks fall up to 3% after Accenture Q2 results. Details here - Mint
Infosys, Wipro ADRs drop over 3% on NYSE after Accenture hikes full-year revenue guidance to 5-7% on AI boom - Mint
Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Track Sharply Lower in Tuesday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Open Week Sharply Higher - TradingView
Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - GlobeNewswire Inc.
Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading - TradingView
Best upcoming stock splits and reverse splits 2024 - Investorsobserver
Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up 1.5% for Week - TradingView
Is TG Therapeutics Inc (NASDAQ: TGTX) A Good Investment For New Investors Now? - Stocks Register
Senores Pharmaceuticals Shares: Rises 7%, acquires 14 ANDAs from Dr. Reddy’s - BusinessLine
Rhumbline Advisers Grows Position in Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat
Dr. Reddy's Laboratories Ltd. Sponsored ADR to Host Earnings Call - ACCESS Newswire
Stocks to watch: Bharti Airtel, Wipro, Coforge, Dr Reddy’s, Vakrangee among shares to remain in focus today - Mint
Share Market Update – Dr Reddy Share Price Target 2025 - LDCCBank
Asian Equities Traded in the US as American Depositary Receipts Tumble in Monday Trading - TradingView
Alvotech heldur kynningarfund fyrir fjárfesta 27. mars 2025, eftir birtingu uppgjörs fyrir árið 2024 og fjórða ársfjórðung - GlobeNewswire Inc.
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading, Up 2.2% for Week - MSN
Its Stock Has Paid Off Big Time For Dr. Reddy’s Laboratories Ltd. ADR - SETE News
Marshall Wace, DE Shaw, Millennium Helped Drive China ADR Surges - Mint
Lester Murray Antman dba SimplyRich Increases Stock Position in Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading; End Week Up 2% - TradingView
Asian Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - TradingView
Indian ADRs Alert! Why Infosys, Wipro, HDFC Bank, ICICI Bank, Dr Reddy's Lab Will Be In Focus On February 13? - Goodreturns
Taking on analysts’ expectations and winning: Dr. Reddy’s Laboratories Ltd. ADR (RDY) - SETE News
Dr. Reddy’s Laboratories Ltd. ADR [NYSE: RDY] Sees Decrease in Stock Value - Knox Daily
Nothing is Better Than Sociedad Quimica Y Minera de Chile S.A. ADR (SQM) stock at the moment - SETE News
Ecolab, Inc (ECL) expanding its growth trajectory ahead - SETE News
A look into Golar Lng (GLNG)’s deeper side - SETE News
Altria Group Inc [NYSE: MO] Sees Increase in Stock Value - Knox Daily
Moody’s Corp [MCO] Shares Jump Approximately 26.66% Over the Year - Knox Daily
Understanding the 1.67% Volatility Levels of Dr. Reddy’s Laboratories Ltd. ADR’s (RDY) Stock in the Past 30 Days - The News Heater
LLY Stock Quote Price and Forecast - CNN
Dr. Reddy’s Faces GST Penalty, Evaluates Appeal - TipRanks
Of 5 billionaires contesting today’s Delhi elections, 3 are from BJP: Know their net worths - Mint
Dr Reddy's Labs shares slide 6% post Q3 results. Should you buy, sell, or hold? - The Economic Times
Dr. Reddy’s Labs ADR earnings missed by $0.02, revenue fell short of estimates - Investing.com
Coupang Inc (NYSE: CPNG): A Blank Check? - Stocks Register
Dr Reddys Laboratories Ltd Adr Azioni (RDY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):